Drew Ronnermann
Gastroenterology · Pottstown, PANPI 1235101999
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 316 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 25.0% of the total. Reporting peaked in 2022 at $1,748 and has fallen 92.2% since, to $136 in 2023.
Across 316 payments — averaging $16.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Takeda Pharmaceuticals U.S.A., Inc.$530
- Johnson & Johnson$355
- Gilead$235
- Bristol Myers Squibb$208
- plus $1K from 26 others
What the payments were for
- Food & beverage$5,01699%
- Gifts$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 75 | $1,269 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 83 | $1,098 |
| Takeda Pharmaceuticals U.S.A., Inc. | 35 | $530 |
| Johnson & Johnson(2 entities) | 18 | $355 |
| Gilead | 18 | $235 |
| Bristol Myers Squibb | 12 | $208 |
| Intercept Pharmaceuticals, Inc. | 9 | $141 |
| Merck | 9 | $134 |
| Braintree Laboratories, Inc. | 5 | $132 |
| Shionogi Inc | 5 | $109 |
| Ironwood Pharmaceuticals, Inc | 6 | $99 |
| Pfizer | 4 | $79 |
| Daiichi Sankyo Inc. | 4 | $75 |
| Nestle Healthcare Nutrition Inc. | 4 | $70 |
| QOL Medical, LLC | 3 | $67 |
| GSK | 4 | $56 |
| Sanofi | 2 | $47 |
| Ferring Pharmaceuticals Inc. | 3 | $43 |
| UCB, Inc. | 2 | $42 |
| Alnylam Pharmaceuticals Inc. | 2 | $38 |
| Concordia Pharmaceuticals Inc. | 2 | $29 |
| AstraZeneca | 1 | $25 |
| Boston Scientific | 1 | $24 |
| Advanced Respiratory, Inc | 1 | $24 |
| Nevro Corp. | 1 | $23 |
| Shire North American Group Inc | 1 | $23 |
| Romark Laboratories, LC | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $16 |
| Philips North America LLC | 1 | $14 |
| Medtronic | 1 | $12 |
| Amgen | 1 | $11 |
How this compares
$5,069 in reported general payments places this provider in the 65th percentile of 935 gastroenterology providers in Pennsylvania.
Other gastroenterology in Pottstown
- Miguel RegueiroPittsburgh$1.5M
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Sandra El-HachemPittsburgh$472K
- Harshit KharaDanville$438K
- Kofi ClarkeHershey$426K
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
- Elie AounPittsburgh$323K
- Andrew TinsleyHershey$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.